Introduction Optimizing medication use is a major issue in older patients with cancer and
pharmacists are increasingly involved in their multidisciplinary care. The implementation of …

Background Preventable harm in healthcare is a growing public health challenge. In
addition to the economic costs of safety failures, adverse drug events (ADE) may lead to …

In addition to frailty, two novel concepts have been introduced in the field of geriatrics to
capture the heterogeneous ageing process: the first is intrinsic capacity, which uses a …

Objectives Immune checkpoint inhibitor immunotherapy (IO) is revolutionizing cancer care
but can lead to significant toxicity. This study seeks to describe potential risk factors for …

Introduction As treatment options for metastatic castration-resistant prostate cancer
(mCRPC) expand and its patient population ages, consideration of frailty is increasingly …

Purpose Older adults with hematologic malignancies (HM) have unique challenges due to
age and fitness. The primary aim of this pilot study was to benchmark the ability of multiple …

Background Frailty negatively affects the outcomes of patients with cancer, and its
assessment might vary widely in the real world. The objective of this study was to explore …

Background Many older adults with cancer have≥ 2 impairments on geriatric assessment,
which affects present and future frailty status, treatment tolerability, and outcomes. Our …

Introduction Exploring symptom experiences of older men during metastatic prostate cancer
treatment can help clinicians identify unmet supportive care needs that, if addressed, could …

Background: Androgen deprivation therapy (ADT) is a mainstay of prostate cancer in both
adjuvant and palliative settings. Since androgens are crucial for functional status and …